seed
Stage
1
Investors
About
Insamo develops an automated platform that designs, synthesizes, and tests membrane-permeable and orally available cyclic peptides at scale to accelerate drug discovery for challenging diseases.
Explore Insamo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.